CAR-T Cell Therapy and Beyond - Novartis
Novartis is pioneering the way in the class of cell and gene treatment and has developed the first CAR-T cell therapy approved for paediatric and young adult patients with relapsed/refractory B …
CAR-T Cell Therapy: Pioneering Cancer Therapy | Novartis
By sharing personal perspectives, we hope to empower patients and caregivers to learn more about CAR-T cell therapy and shed light on some of the most important, but sometimes less …
Novartis announces T-Charge™, next-generation CAR-T platform …
Dec 13, 2021 · T-Charge is a next-generation CAR-T platform, innovated at the Novartis Institutes for BioMedical Research (NIBR), that will serve as the foundation for various new …
Novartis receives first ever FDA approval for a CAR-T cell therapy ...
Aug 30, 2017 · Novartis receives first ever FDA approval for a CAR-T cell therapy, Kymriah (TM) (CTL019), for children and young adults with B-cell ALL that is refractory or has relapsed at …
Cell Therapy - Novartis
Novartis has a deep CAR-T pipeline. Our focus is to broaden the impact of cell therapy in oncology by going deeper in B-cell malignancies, potentially reaching patients in other …
The Process of CAR-T Cell Therapy - Novartis
Novartis is the first to develop CAR-T cell therapy in collaboration with an academic institution. Novartis partnered with the University of Pennsylvania to pioneer the commercial CAR-T cell …
The Science of CAR-T Cell Therapy - Novartis
Novartis Pharma AG; 2018. Milone MC, Fish JD, Carpenito C, et al. Chimeric receptors containing CD137 signal transduction domains mediate enhanced survival of T cells and increased …
Manufacturing CAR-T Cell Therapies: The Novartis Approach
Novartis has created a sophisticated process for manufacturing CAR T Cell Therapies. Novartis CAR-T Cell theapy is developed using the patient's own T-Cells which are part of the body …
CAR-T therapies are manufactured for each individual patient
Oct 13, 2017 · Through a collaboration with the University of Pennsylvania (Penn), Novartis made an early commitment to the emerging field of CAR-T therapies. Its facility in Morris Plains, New …
Novartis Pipeline
Discover the Novartis pipeline of over 100 projects in clinical development, many for medicines that could advance treatment standards for patients.